Abstract
Short chain aliphatic alcohols have previously been found to enhance fMLP binding to human neutrophils, presumably by non-specific mechanisms involving increased membrane hydrophobicity or decreased microviscosity. We report the discovery of highly potent fMLP binding enhancers with 30 000 times the potency of the alcohols. Activity of the compounds is specific since slight changes in structure drastically alter their ability to enhance binding and since closely related compounds inhibit rather than enhance binding. The effects of experimental compounds on enhancement or inhibition of fMLP binding are paralleled by similar actions on fMLP-stimulated shape change of neutrophils.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
I. M. Goldstein,Phagocytic cells: chemotaxis & effector functions of macrophages & granulocytes II Granulocytes. In Basic & Clinical Immunology, 5th edition. (Eds. D. P. Stites, J. D. Stobo, H. H. Fudenberg and J. V. Wells) pp. 114–118. Lange Medical Publications, Los Altos (1984).
E. Schiffmann, H. V. Showell, B. A. Corcoran, P. A. Ward, E. Smith and E. L. Becker,The isolation and partial, characterization of neutrophil chemotactic factors from Escherichia coli. J. Immunol.114, 1831–1837 (1975).
W. A. Marasco, S. H. Phan, H. Krutzsch, H. J. Showell, D. E. Feltner, R. Nairn, E. L. Becker and P. A. Ward,Purification and identification of formyl-methionyl-leucylphenylalanine (f-Met-Leu-Phe) as the major peptide neutrophil chemotactic factor produced by Escherichia coli. J. Biol. Chem.259, 5430–5439 (1984).
C. S. Liao and R. J. Freer,Cryptic receptors for chemotactic peptides in rabbit neutrophils. Biochem. Biophys. Res. Commun.93, 566–571 (1980).
M. P. Fletcher, B. S., Seligmann and J. I. Gallin,Correlation of human neutrophil secretion, chemoattractant receptor mobilization, and enhanced functional capacity. J. Immunol.128, 941–948 (1982).
A. Tomonaga, M. Hirota and R. Snyderman,Effect of membrane fluidizers on the number and affinity of chemotactic factor receptors on human polymorphonuclear leucocytes. Microbiol. Immunol.27, 961–972 (1983).
I. Yuli, A. Tomonaga and R. Snyderman,Chemoattractant receptor functions in human polymorphonuclear leukocytes are divergently altered by membrane fluidizers. Proc. Natl. Acad. Sci. USA79, 5906–5910 (1982).
G. Rimon, E. Hanski, S. Braun and A. Levitzki,Mode of coupling between hormone receptors and adenylate cyclase elucidated by modulation of membrane fluidity. Nature276, 394–396 (1978).
R. D. Nelson, V. D. Fiegel, D. F. Stroncek and G. M. Vercellotti,Definition of two mobilizable pools of peptide receptors for human neutrophils, J. Leuk. Biol.36, 422 (1984).
H. R. Lamche, P. T. Silberstein, A. C. Knabe, D. Thomas, H. S. Jacob and D. E. Hammerschmidt,High-dose steroids decrease granulocyte membrane fluidity, disrupting agonist receptor function: studies with spin resonance. Clin. Res.32, 789A (1984).
Author information
Authors and Affiliations
Additional information
Author for correspondence.
Rights and permissions
About this article
Cite this article
Psychoyos, S., Smith, C.W. Enhancement of N-formyl-methionyl-leucyl-phenylalanine (fMLP) binding to isolated human neutrophils. Agents and Actions 26, 372–377 (1989). https://doi.org/10.1007/BF01967304
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF01967304